Kurse Bellevue Life Sciences Acquisition Corp.
Aktien
A3DLM3
US0791741087
BLAC
Holdinggesellschaften
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
10.8 USD | +0.37% | -1.01% | +2.86% |
5-Tages-Kurse
verzögerte Kurse Nasdaq10.05.2024 | 13.05.2024 | 15.05.2024 | 16.05.2024 | |
---|---|---|---|---|
Kurs | 10.91 $ | 10.72 $ | 10.76 $ | 10.8 $ |
Volumen | 4 129 | 4 421 | 5 090 | 5 707 |
Veränderung | +1.02% | -1.74% | +0.37% | +0.37% |
Eröffnung | 10.97 | 11.12 | 11.00 | 10.99 |
Hoch | 11.10 | 11.12 | 11.00 | 11.01 |
Tief | 10.89 | 10.72 | 10.73 | 10.80 |
Performance
1 Tag | +0.37% | ||
1 Woche | -1.01% | ||
Aktueller Monat | +0.65% | ||
1 Monat | +0.93% | ||
3 Monate | +2.27% | ||
6 Monate | +3.10% | ||
Laufendes Jahr | +2.86% | ||
1 Jahr | +5.88% |
Volumen
MärkteBasisdaten
Extremkurse
Indikatoren
Sektorenvergleich - Briefkastenfirmen
Name | % | % 5 Tage | % 1. Jan. | % 1 Jahr | Kap. | |
---|---|---|---|---|---|---|
+0.37% | -1.01% | +2.86% | +5.88% | 60.73 Mio. | ||
-2.37% | -0.15% | +190.94% | +286.31% | 6.96 Mrd. | ||
-0.05% | +0.05% | +2.14% | +4.84% | 982 Mio. | ||
-14.00% | -.--% | +41.91% | +43.33% | 872 Mio. | ||
+1.24% | +2.04% | +26.98% | +96.83% | 830 Mio. | ||
-0.05% | 0.00% | +1.72% | - | 664 Mio. | ||
-0.84% | -4.84% | +5.92% | - | 642 Mio. | ||
-.--% | -.--% | -.--% | -.--% | 600 Mio. | ||
0.00% | 0.00% | +3.61% | -4.85% | 503 Mio. | ||
-.--% | -.--% | - | - | 500 Mio. | ||
+2.12% | -4.67% | -16.71% | - | 470 Mio. | ||
+12.50% | -.--% | -.--% | +12.50% | 450 Mio. | ||
-.--% | -2.56% | - | - | 445 Mio. | ||
-0.10% | -0.10% | - | - | 441 Mio. | ||
-.--% | -.--% | -.--% | -.--% | 429 Mio. | ||
-0.99% | -3.85% | -76.91% | - | 425 Mio. | ||
Durchschnitt | -0.14% | -0.88% | +14.04% | +49.43% | ||
Gewichteter Durchschnitt nach Marktkapitalisierung | -1.45% | -0.49% | +97.67% | +181.32% |
Historische Daten
Datum | Eröffnung | Hoch | Tief | Schlusskurs | Volumen |
---|
Monatliche Veränderungen
Jährliche Veränderungen
2024 | +2.86% | ||
2023 | +3.96% |
- Börse
- Aktien
- A3DLM3 Aktie
- Kurse Bellevue Life Sciences Acquisition Corp.